By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Greer Labs 

P.O.Box 800

Lenior  North Carolina  28645  U.S.A.
Phone: 800-378-3906 Fax: 1-800-419-7302


SEARCH JOBS


Industry
Biotechnology






Company News
Greer Labs Announces Rick Russell As New President And CEO 11/13/2014 10:58:19 AM
Greer Labs Launches ORALAIR®, The First And Only Sublingual Allergy Immunotherapy Tablet With A Mix Of Five Grass Allergens For The Treatment Of Grass Pollen Allergy 5/5/2014 10:02:26 AM
Greer Labs and Stallergenes, S.A. (GENP.PA) Sign Exclusive Agreement for United States Commercialization Rights to Oralair® 10/31/2013 12:30:46 PM
Greer Labs and Stallergenes, S.A. (GENP.PA) Sign Exclusive Agreement for United States Commercialization Rights to Oralair® 10/31/2013 12:24:36 PM
Greer Labs Reports Positive Findings from Large Phase III Clinical Trial Evaluating Sublingual Immunotherapy for Ragweed Allergies 6/12/2012 10:34:01 AM
Greer Labs Announces Veterinary Partnership With IDEXX Laboratories, Inc. (IDXX) 5/15/2012 10:37:22 AM
Greer Labs Release: Landmark Allergy Study Uncovers Significant Healthcare Savings Associated with Immunotherapy in Children 11/11/2008 9:48:04 AM
Greer Labs Completes Enrollment for Pivotal Phase III Clinical Trial Evaluating the Efficacy of Sublingual-Oral Immunotherapy for Treating Short Ragweed Allergies 6/26/2008 9:32:44 AM
Greer Labs's Sublingual-Oral Immunotherapy Clinical Trials Supporting the Safety of Home-Administered Treatment Published in the Annals of Allergy, Asthma and Immunology 3/17/2008 9:21:44 AM
Greer Launches Phase III Trial to Study Efficacy of Sublingual-Oral Immunotherapy in Patients with Allergic Rhinoconjunctivitis 3/14/2008 9:52:07 AM
123
//-->